Double-blind comparison of meglumine iodamide and Renografin-60 for excretory urography.
A double blind comparison of meglumine iodamide and Renografin-60 in bolus intravenous pyelography, using 50 ml of contrast or less, was conducted in 78 patients. Meglumine iodamide produced more dense opacifications, but it also produced a greater number of laboratory abnormalities. All were transient and mild. No serious abnormalities resulted from the use of either agent.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003973:Diatrizoate / Q000031:analogs & derivatives*; D003974:Diatrizoate Meglumine / Q000009:adverse effects; D005260:Female; D006801:Humans; D007451:Iodamide / Q000031:analogs & derivatives; D007463:Iodobenzoates; D008297:Male; D008536:Meglumine / Q000009:adverse effects; D008875:Middle Aged; D011856:Radiographic Image Enhancement; D014567:Urography; D014570:Urologic Diseases / Q000000981:diagnostic imaging
D007463:Iodobenzoates; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D007451:Iodamide; D008536:Meglumine